Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


20.11.2017

1 AIDS
1 Am J Gastroenterol
1 Arch Virol
2 Cancer
1 Clin Infect Dis
3 Gastroenterol Hepatol
1 Gastroenterology
1 J Hepatol
1 J Infect Dis
1 J Interferon Cytokine Res
2 J Viral Hepat
1 J Virol
1 Lancet
4 Lancet Gastroenterol Hepatol
5 PLoS One
1 Transplant Proc
1 Transplantation
2 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. MINGUEZ C, Garcia-Deltoro M, Flores J, Galindo MJ, et al
    Interferon-free therapy for treating HCV in difficult-to-treat HIV-coinfected patients as implemented in routine medical practice.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001699.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  2. KWO PY, Shiffman ML, Bernstein DE
    The Cochrane Review Conclusion for Hepatitis C DAA Therapies is Wrong.
    Am J Gastroenterol. 2017 Nov 14. doi: 10.1038/ajg.2017.
    PubMed     Text format    


    Arch Virol

  3. YANG S, Xing H, Feng S, Ju W, et al
    Prevalence of NS5B resistance-associated variants in treatment-naive Asian patients with chronic hepatitis C.
    Arch Virol. 2017 Nov 15. doi: 10.1007/s00705-017-3640.
    PubMed     Text format     Abstract available


    Cancer

  4. ECONOMIDES MP, Amit M, Mahale PS, Hosry JJ, et al
    Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer.
    Cancer. 2017 Nov 17. doi: 10.1002/cncr.31146.
    PubMed     Text format     Abstract available

  5. MA GX, Lee MM, Tan Y, Hanlon AL, et al
    Efficacy of a community-based participatory and multilevel intervention to enhance hepatitis B virus screening and vaccination in underserved Korean Americans.
    Cancer. 2017 Nov 13. doi: 10.1002/cncr.31134.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  6. BEDIMO RJ, Adams-Huet B, Poindexter J, Brown G, et al
    The Differential Effects of HIV and HCV on Bone Micro-Architecture and Fracture risk.
    Clin Infect Dis. 2017 Nov 14. doi: 10.1093/cid/cix1011.
    PubMed     Text format     Abstract available


    Gastroenterol Hepatol

  7. DIAZ-RAMIREZ GS, Marin-Zuluaga JI, Donado-Gomez JH, Munoz-Maya O, et al
    Characterization of patients with autoimmune hepatitis at an university hospital in Medellin-Colombia: cohort study.
    Gastroenterol Hepatol. 2017 Nov 7. pii: S0210-5705(17)30222.
    PubMed     Text format     Abstract available

  8. MONTESERIN L, Jimenez M, Linares P, Rodriguez-Martin L, et al
    Acute hepatitis secondary to high-dose intravenous methylprednisolone.
    Gastroenterol Hepatol. 2017 Nov 10. pii: S0210-5705(17)30221.
    PubMed     Text format    

  9. ACERO FERNANDEZ D, Ferri Iglesias MJ, Buxo Pujolras M, Lopez Nunez C, et al
    Changes in the epidemiology and distribution of the hepatitis C virus genotypes in North-Eastern Spain over the last 35 years.
    Gastroenterol Hepatol. 2017 Nov 14. pii: S0210-5705(17)30224.
    PubMed     Text format     Abstract available


    Gastroenterology

  10. DIETZ J, Susser S, Vermehren J, Peiffer KH, et al
    Patterns of Resistance-associated Substitutions in Patients With Chronic HCV Infection Following Treatment with Direct-acting Antivirals.
    Gastroenterology. 2017 Nov 13. pii: S0016-5085(17)36353.
    PubMed     Text format     Abstract available


    J Hepatol

  11. BUGGISCH P, Vermehren J, Mauss S, Gunther R, et al
    Real-world effectiveness of 8 weeks treatment with ledipasvir/sofosbuvir in chronic hepatitis C.
    J Hepatol. 2017 Nov 10. pii: S0168-8278(17)32431.
    PubMed     Text format     Abstract available


    J Infect Dis

  12. STEBA GS, Koekkoek SM, Vanhommerig JW, Brinkman K, et al
    DC-SIGN Polymorphisms Associated with Risk of Hepatitis C Virus Infection Among Men who Have Sex with Men but not Among Injecting Drug Users.
    J Infect Dis. 2017 Nov 13. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Interferon Cytokine Res

  13. ALTRAIF IH, Sanai F, Babatin MA, Alalwan AA, et al
    Pharmacokinetics-Based Adjusted Versus Standard Dose of Ribavirin Does Not Improve Virologic Response Rates in Chronic Hepatitis C Genotype 4 Patients: A Randomized Controlled Trial.
    J Interferon Cytokine Res. 2017;37:488-493.
    PubMed     Text format     Abstract available


    J Viral Hepat

  14. DUCHESNE L, Lacombe K
    Innovative technologies for point-of-care testing of viral hepatitis in low-resource and decentralized settings.
    J Viral Hepat. 2017 Nov 13. doi: 10.1111/jvh.12827.
    PubMed     Text format     Abstract available

  15. LI X, Gou C, Yao L, Lei Z, et al
    Patients with HBV-related acute-on-chronic liver failure have increased concentrations of extracellular histones aggravating cellular damage and systemic inflammation.
    J Viral Hepat. 2017;24:59-67.
    PubMed     Text format     Abstract available


    J Virol

  16. DIXIT U, Pandey AK, Liu Z, Kumar S, et al
    Correction for Dixit et al., "FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53".
    J Virol. 2017;91.
    PubMed     Text format    


    Lancet

  17. THE LANCET
    Eliminating viral hepatitis: time to match visions with action.
    Lancet. 2017;390:2121.
    PubMed     Text format    


    Lancet Gastroenterol Hepatol

  18. MURPHY CJ, Bhatt A, Chen W, Malli A, et al
    Syphilitic hepatitis.
    Lancet Gastroenterol Hepatol. 2017;2:920.
    PubMed     Text format    

  19. SONDERUP MW, Afihene M, Ally R, Apica B, et al
    Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030.
    Lancet Gastroenterol Hepatol. 2017;2:910-919.
    PubMed     Text format     Abstract available

  20. SPEARMAN CW, Afihene M, Ally R, Apica B, et al
    Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets.
    Lancet Gastroenterol Hepatol. 2017;2:900-909.
    PubMed     Text format     Abstract available

  21. PARKER R
    Alcoholic hepatitis: calling time on an unhelpful diagnosis.
    Lancet Gastroenterol Hepatol. 2017;2:845-847.
    PubMed     Text format    


    PLoS One

  22. STROFFOLINI T, Sagnelli E, Andriulli A, Colloredo G, et al
    Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis.
    PLoS One. 2017;12:e0185710.
    PubMed     Text format     Abstract available

  23. SHIMIZU JF, Pereira CM, Bittar C, Batista MN, et al
    Multiple effects of toxins isolated from Crotalus durissus terrificus on the hepatitis C virus life cycle.
    PLoS One. 2017;12:e0187857.
    PubMed     Text format     Abstract available

  24. YANG A, Guo Z, Ren Q, Wu L, et al
    Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study.
    PLoS One. 2017;12:e0188190.
    PubMed     Text format     Abstract available

  25. YINDOM LM, Mendy M, Bodimeade C, Chambion C, et al
    KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians.
    PLoS One. 2017;12:e0188307.
    PubMed     Text format     Abstract available

  26. GARRIGA C, Manzanares-Laya S, Garcia de Olalla P, Gorrindo P, et al
    Evolution of acute hepatitis C virus infection in a large European city: Trends and new patterns.
    PLoS One. 2017;12:e0187893.
    PubMed     Text format     Abstract available


    Transplant Proc

  27. TOWNSEND SA, Monga MA, Nightingale P, Mutimer D, et al
    Hepatitis C Virus Recurrence Occurs Earlier in Patients Receiving Donation After Circulatory Death Liver Transplant Grafts Compared With Those Receiving Donation After Brainstem Death Grafts.
    Transplant Proc. 2017;49:2129-2134.
    PubMed     Text format     Abstract available


    Transplantation

  28. KAMAR N, Del Bello A, Izopet J
    Should persistent hepatitis E virus replication in transplant patients be tolerated?
    Transplantation. 2017 Nov 10. doi: 10.1097/TP.0000000000001994.
    PubMed     Text format    


    Vaccine

  29. HUO C, Yang J, Lei L, Qiao L, et al
    Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
    Vaccine. 2017 Nov 9. pii: S0264-410X(17)31530.
    PubMed     Text format     Abstract available

  30. PETIT D, Tevi-Benissan C, Woodring J, Hennessey K, et al
    Countries' interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regions.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31421.
    PubMed     Text format     Abstract available


    Virology

  31. MESALAM AA, Desombere I, Farhoudi A, Van Houtte F, et al
    Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.
    Virology. 2017;514:30-41.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: